Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Heredity|October 1, 1981
The advantages of analysing human variation using twins and twin half-sibs and cousinsC S Haley, K LastInternational Journal of Immunopharmacology|January 1, 1985
Potential use of human interleukin 2 as an adjunct for the therapy of neoplasia, immunodeficiency and infectious diseaseV J Merluzzi, K Last-BarneyJournal of Biological Response Modifiers|October 1, 1984
Expansion of murine cytotoxic precursors in vitro and in vivo by purified interleukin-2V J Merluzzi, K Last-BarneyThe Journal of Clinical Investigation|November 15, 1996
Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independentA J Fosang, K Last, R A MaciewiczHeredity|April 1, 1981
The monozygotic twin half-sib method for analysing maternal effects and sex-linkage in humansC S Haley, J L Jinks, K LastInternational Journal of Immunopharmacology|January 1, 1983
Comparison of 2'-fluoro-arabinosyl pyrimidine nucleosides and 1-beta-D-arabinofuranosylcytosine on immunological parameters in vitroV J Merluzzi, K Last-Barney, J J FoxScience (New York, N.Y.)|November 12, 1982
Sensitivity to carcinogenesis in nude mice: skin tumors caused by transplacental exposure to ethylnitrosoureaL M Anderson, K Last-Barney, J M BudingerCellular Immunology|July 1, 1986
Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cellsV J Merluzzi, M D Smith, K Last-BarneyJournal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrowV J Merluzzi, P A Trail, K Last-BarneyFEBS Letters|September 1, 2005
Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycanS Knox, A J Fosang, K Last, et al.Pageof 5